05-23-0150 Sigma-Aldrich[Arg⁸]-Vasopressin
Productos recomendados
Descripción
Replacement Information |
---|
References | |
---|---|
References | Mihara, T., et al. 1999. Brain Res. Bull. 49, 343. Kobayashi, H., et al. 1994. Brain Res. 647, 145. Monaghan, M.L., et al. 1993. Gen. Pharmacol. 24, 1013. |
Product Information | |
---|---|
CAS number | 113-79-1 |
Form | Lyophilized |
Formulation | Supplied as a trifluoroacetate salt. |
Hill Formula | C₄₆H₆₅N₁₅O₁₂S₂ |
Chemical formula | C₄₆H₆₅N₁₅O₁₂S₂ |
Sold on the basis of peptide content | Y |
Applications |
---|
Biological Information | |
---|---|
Purity | ≥97% by HPLC |
Physicochemical Information | |
---|---|
Peptide Content | Y |
Peptide Sequence | H-Cys¹-Tyr-Phe-Gln-Asn-Cys⁶-Pro-Arg-Gly-NH₂ (disulfide bond: 1 → 6) |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information | |
---|---|
R Phrase | R: 20 Harmful by inhalation. |
S Phrase | S: 36 Wear suitable protective clothing. |
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
05-23-0150 | 0 |
Documentation
Licencias necesarias
Título |
---|
PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD |
[Arg⁸]-Vasopressin Certificados de análisis
Cargo | Número de lote |
---|---|
05-23-0150 |
Referencias bibliográficas
Visión general referencias |
---|
Mihara, T., et al. 1999. Brain Res. Bull. 49, 343. Kobayashi, H., et al. 1994. Brain Res. 647, 145. Monaghan, M.L., et al. 1993. Gen. Pharmacol. 24, 1013. |